Researchers Believe Pancreatic Cancer Is Four Separate Diseases

This article originally appeared here.
Share this content:
Researchers Say Pancreatic Cancer Is Four Separate Diseases
Researchers Say Pancreatic Cancer Is Four Separate Diseases

(HealthDay News) -- Scientists who discovered that pancreatic cancer is at least four separate diseases say their findings could lead to improved treatments for the disease.

The researchers studied pancreatic cancer in 456 patients and identified four classes of genetic error that triggered tumors. They labeled the four cancers: squamous-type; pancreatic progenitor; immunogenic; and aberrantly differentiated endocrine exocrine, BBC News reported. The findings were published online Feb. 24 in Nature.

"This is the most comprehensive analysis of the blueprint of pancreatic cancer. So this knowledge reveals what makes these cancers tick and which ones may be vulnerable to particular treatments by defining the Achilles' heel of every cancer," Andrew Biankin, M.B.B.S., Ph.D., one of the researchers at the University of Glasgow in the United Kingdom, told BBC News.

At diagnosis, most pancreatic cancer patients are told they have less than a year to live. Only one percent of patients are alive after 10 years, a survival rate that's remained the same for four decades.

One author disclosed financial ties to Myriad Genetics.

Full Text (subscription or payment may be required)

You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs